Statistics
| Views | |
|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 648 |
| March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | August 2026 | September 2026 | |
|---|---|---|---|---|---|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 3 | 23 | 21 | 22 | 32 | 24 | 1 |
| Views | |
|---|---|
| TD_2019_debelder_011.pdf | 695 |
| Views | |
|---|---|
| United States | 145 |
| Argentina | 102 |
| Canada | 44 |
| Peru | 35 |
| Mexico | 28 |
| Spain | 21 |
| Brazil | 18 |
| Colombia | 15 |
| Ecuador | 13 |
| Chile | 12 |
| Views | |
|---|---|
| Ottawa | 36 |
| Buenos Aires | 28 |
| Lima | 20 |
| Houston | 16 |
| Mexico | 12 |
| Federal | 10 |
| Tokyo | 10 |
| Quito | 9 |
| Hanoi | 8 |
| Menlo Park | 7 |